File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Neurotensins and their therapeutic potential: research field study

TitleNeurotensins and their therapeutic potential: research field study
Authors
KeywordsParkinson´s disease
neurodegenerative diseases
neurotensin
peptidomimetics
Issue Date2020
PublisherFuture Science Ltd. The Journal's web site is located at https://www.future-science.com/journal/fmc
Citation
Future Medicinal Chemistry, 2020, v. 12 n. 19, p. 1779-1803 How to Cite?
AbstractThe natural tridecapeptide neurotensin has been emerged as a promising therapeutic scaffold for the treatment of neurological diseases and cancer. In this work, we aimed to identify the top 100 most cited original research papers as well as recent key studies related to neurotensins. The Web of Science Core Collection database was searched and the retrieved research articles were analyzed by using the VOSviewer software. The most cited original articles were published between 1973 and 2013. The top-cited article was by Carraway and Leeman reporting the discovery of neurotensin in 1973. The highly cited terms were associated with hypotension and angiotensin-converting-enzyme. The conducted analysis reveals the therapeutic potentials of neurotensin, and further impactful research toward its clinical development is warrantied.
Persistent Identifierhttp://hdl.handle.net/10722/290869
ISSN
2020 Impact Factor: 3.808
2020 SCImago Journal Rankings: 0.708
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorYeung, AWK-
dc.contributor.authorGeorgieva, MG-
dc.contributor.authorKirilov, K-
dc.contributor.authorBalacheva, AA-
dc.contributor.authorPeeva, MI-
dc.contributor.authorHorbańczuk, OK-
dc.contributor.authorHorbańczuk, JO-
dc.contributor.authorLucarini, M-
dc.contributor.authorDurazzo, A-
dc.contributor.authorSantini, A-
dc.contributor.authorSouto, EB-
dc.contributor.authorPajpanova, TI-
dc.contributor.authorMilella, L-
dc.contributor.authorAtanasov, AG-
dc.contributor.authorTzvetkov, NT-
dc.date.accessioned2020-11-02T05:48:16Z-
dc.date.available2020-11-02T05:48:16Z-
dc.date.issued2020-
dc.identifier.citationFuture Medicinal Chemistry, 2020, v. 12 n. 19, p. 1779-1803-
dc.identifier.issn1756-8919-
dc.identifier.urihttp://hdl.handle.net/10722/290869-
dc.description.abstractThe natural tridecapeptide neurotensin has been emerged as a promising therapeutic scaffold for the treatment of neurological diseases and cancer. In this work, we aimed to identify the top 100 most cited original research papers as well as recent key studies related to neurotensins. The Web of Science Core Collection database was searched and the retrieved research articles were analyzed by using the VOSviewer software. The most cited original articles were published between 1973 and 2013. The top-cited article was by Carraway and Leeman reporting the discovery of neurotensin in 1973. The highly cited terms were associated with hypotension and angiotensin-converting-enzyme. The conducted analysis reveals the therapeutic potentials of neurotensin, and further impactful research toward its clinical development is warrantied.-
dc.languageeng-
dc.publisherFuture Science Ltd. The Journal's web site is located at https://www.future-science.com/journal/fmc-
dc.relation.ispartofFuture Medicinal Chemistry-
dc.rightsPreprint The article has been submitted for publication to [the specified journal].-
dc.subjectParkinson´s disease-
dc.subjectneurodegenerative diseases-
dc.subjectneurotensin-
dc.subjectpeptidomimetics-
dc.titleNeurotensins and their therapeutic potential: research field study-
dc.typeArticle-
dc.identifier.emailYeung, AWK: ndyeung@hku.hk-
dc.identifier.authorityYeung, AWK=rp02143-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.4155/fmc-2020-0124-
dc.identifier.pmid33032465-
dc.identifier.scopuseid_2-s2.0-85094932639-
dc.identifier.hkuros318548-
dc.identifier.volume12-
dc.identifier.issue19-
dc.identifier.spage1779-
dc.identifier.epage1803-
dc.identifier.isiWOS:000581698600001-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl1756-8919-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats